Shandong Xinhua Pharmaceutical Company Limited (HKG:0719)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
6.68
+0.08 (1.21%)
At close: Mar 27, 2026

HKG:0719 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Operating Revenue
8,7558,3247,9567,2956,360
Other Revenue
-142.44144.78207.82200.54
8,7558,4668,1017,5036,560
Revenue Growth (YoY)
3.41%4.51%7.97%14.37%9.23%
Cost of Revenue
7,1106,4815,7795,5154,824
Gross Profit
1,6451,9852,3211,9881,736
Selling, General & Admin
798.741,0171,2871,106929.12
Research & Development
381.62413.18419.24345.66341.37
Other Operating Expenses
22.6335.8892.1865.3159.27
Operating Expenses
1,2081,4751,8091,5221,332
Operating Income
436.2510.63512.15465.87403.67
Interest Expense
-34.57-39.74-41.15-49.71-53.1
Interest & Investment Income
7.7620.9621.8818.8316.79
Currency Exchange Gain (Loss)
-19.0915.4210.53-4.18
Other Non Operating Income (Expenses)
-5.07-3.41-2.72-3.38-2.45
EBT Excluding Unusual Items
404.32507.53505.59442.15360.72
Gain (Loss) on Sale of Assets
1.991.428.735.542.07
Asset Writedown
-47.39-5.12-10.29-2.61-1.88
Other Unusual Items
-29.8228.6526.760.32
Pretax Income
358.92533.65532.69471.77421.23
Income Tax Expense
52.6146.9426.5845.6659.16
Earnings From Continuing Operations
306.3486.71506.11426.11362.07
Minority Interest in Earnings
-16.42-16.69-9.59-15.05-13.53
Net Income
289.89470.02496.51411.06348.55
Net Income to Common
289.89470.02496.51411.06348.55
Net Income Growth
-38.32%-5.33%20.79%17.94%7.29%
Shares Outstanding (Basic)
690682674661627
Shares Outstanding (Diluted)
690688692671627
Shares Change (YoY)
0.29%-0.54%3.20%6.93%-0.02%
EPS (Basic)
0.420.690.740.620.56
EPS (Diluted)
0.420.680.720.610.56
EPS Growth
-38.23%-5.56%18.03%9.75%6.89%
Free Cash Flow
533.73155.19-59.85513.489.89
Free Cash Flow Per Share
0.770.23-0.090.770.02
Dividend Per Share
-0.2750.2500.2000.150
Dividend Growth
-10.00%25.00%33.33%-
Gross Margin
18.79%23.45%28.66%26.50%26.46%
Operating Margin
4.98%6.03%6.32%6.21%6.15%
Profit Margin
3.31%5.55%6.13%5.48%5.31%
Free Cash Flow Margin
6.10%1.83%-0.74%6.84%0.15%
EBITDA
975.041,0491,026952.48840.2
EBITDA Margin
11.14%12.40%12.67%12.70%12.81%
D&A For EBITDA
538.84538.84514.09486.61436.53
EBIT
436.2510.63512.15465.87403.67
EBIT Margin
4.98%6.03%6.32%6.21%6.15%
Effective Tax Rate
14.66%8.80%4.99%9.68%14.04%
Revenue as Reported
8,755--7,503-
Advertising Expenses
-7.468.958.1811.33
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.